doi: 10.1002/art.30314 61 RadnerHAletahaD
Your goal determines protocol intensity and duration
As of 2013, all D SNPs must have contracts with the applicable state Medicaid program that contains a description of how the plan will provide and coordinate Medicare and Medicaid-financed care
Watch for symptoms such as swelling of the face, lips, tongue, or throat, which could indicate anaphylaxis
Low exploratory: 1 nmol/kg subcutaneous (produces a measurable LH pulse within 30 minutes) Moderate support: 3 to 5 nmol/kg subcutaneous, daily or every other day, for 2 to 4 weeks Two forms exist: kisspeptin-54 (full-length, longer-acting, better studied in clinical trials) and kisspeptin-10 (C-terminal fragment, shorter-acting)